Editorial
Dealing with perioperative antiplatelet treatment for transurethral resection of the bladder: primum non nocere
Abstract
The number of patients receiving antithrombotic treatment is increasing (1), thus increasing the number of patients under anticoagulant or antiplatelet treatment scheduled to undergo endo-urology surgery.
